Atlas Trials

Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia

Clinical trial NCT04561180 · WITHDRAWN

Trial details

NCT number
NCT04561180
Sponsor
Evergreen Therapeutics, Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19 Pneumonia
Start date
2022-03-04
Primary completion
2023-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.